Mary Shire

North Plainfield, NJ, United States of America

Mary Shire

This inventor holds 20 USPTO granted patents, primarily in Immunotherapeutic Agents. Top assignee: Celgene Corporation. Active years: 1997-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Shire. Retrieved from https://idiyas.com/inventor/mary-shire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 2.3

ph-index = 12

Forward Citations = 648(Granted Patents)


Company Filing History:


Years Active: 1997-2008

Loading Chart...
Areas of Expertise:
Immunotherapeutic Agents
Cyclic Amides
Substituted Imides
Aryl Amides
Cytokine Inhibitors
Immunotherapeutic Nitriles
Imides
Amides
20 patents (USPTO):Explore Patents

Title: The Innovative Mind of Mary Shire

Introduction: Mary Shire, a pioneering inventor based in North Plainfield, NJ, is known for her groundbreaking contributions to various industries.

Latest Patents: Mary Shire's latest patents include a revolutionary design for a sustainable packaging material and a cutting-edge technology for renewable energy storage.

Career Highlights: With a career spanning over two decades, Mary Shire has established herself as a leading figure in the field of sustainable innovation. Her work has been recognized globally for its impact on environmental conservation and technological advancement.

Collaborations: Throughout her career, Mary Shire has collaborated with top research institutions, universities, and companies to bring her innovative ideas to life. Her partnerships have led to the development of cutting-edge products that have reshaped industries.

Conclusion: Mary Shire's dedication to innovation and sustainability continues to inspire future generations of inventors. Her relentless pursuit of excellence and commitment to making the world a better place through her inventions make her a true trailblazer in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…